大葉大學圖書館 |

Advances in nanotheranostics II[electronic resource] :cancer theranostic nanomedicine /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	610.28
書名/作者:	Advances in nanotheranostics II : cancer theranostic nanomedicine // edited by Zhifei Dai.
其他作者:	Dai, Zhifei.
出版者:	Singapore : : Springer Singapore :, 2016.
面頁冊數:	xi, 381 p. : : ill., digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Nanomedicine.
標題:	Nanostructured materials.
標題:	Engineering.
標題:	Biomedical Engineering.
標題:	Nanotechnology.
標題:	Imaging / Radiology.
標題:	Biomaterials.
標題:	Oncology.
ISBN:	9789811000638
ISBN:	9789811000614
摘要、提要註:	This book surveys recent advances in theranostics based on magnetic nanoparticles, ultrasound contrast agents, silica nanoparticles and polymeric micelles. It presents magnetic nanoparticles, which offer a robust tool for contrast enhanced MRI imaging, magnetic targeting, controlled drug delivery, molecular imaging guided gene therapy, magnetic hyperthermia, and controlling cell fate. Multifunctional ultrasound contrast agents have great potential in ultrasound molecular imaging, multimodal imaging, drug/gene delivery, and integrated diagnostics and therapeutics. Due to their diversity and multifunctionality, polymeric micelles and silica-based nanocomposites are highly capable of enhancing the efficacy of multimodal imaging and synergistic cancer therapy. This comprehensive book summarizes the main advances in multifunctional nanoprobes for targeted imaging and therapy of gastric cancer, and explores the clinical translational prospects and challenges. Although more research is needed to overcome the substantial obstacles that impede the development and availability of nanotheranostic products, such nontrivial nanoagents are expected to revolutionize medical treatments and help to realize the potential of personalized medicine to diagnose, treat, and follow-up patients with cancer. Zhifei Dai is a Professor at the Department of Biomedical Engineering, College of Engineering, Peking University, China.
電子資源:	http://dx.doi.org/10.1007/978-981-10-0063-8

Advances in nanotheranostics II[electronic resource] :cancer theranostic nanomedicine /
Advances in nanotheranostics IIcancer theranostic nanomedicine /[electronic resource] :edited by Zhifei Dai. - Singapore :Springer Singapore :2016. - xi, 381 p. :ill., digital ;24 cm. - Springer series in biomaterials science and engineering,72195-0644 ;. - Springer series in biomaterials science and engineering ;v.3..

This book surveys recent advances in theranostics based on magnetic nanoparticles, ultrasound contrast agents, silica nanoparticles and polymeric micelles. It presents magnetic nanoparticles, which offer a robust tool for contrast enhanced MRI imaging, magnetic targeting, controlled drug delivery, molecular imaging guided gene therapy, magnetic hyperthermia, and controlling cell fate. Multifunctional ultrasound contrast agents have great potential in ultrasound molecular imaging, multimodal imaging, drug/gene delivery, and integrated diagnostics and therapeutics. Due to their diversity and multifunctionality, polymeric micelles and silica-based nanocomposites are highly capable of enhancing the efficacy of multimodal imaging and synergistic cancer therapy. This comprehensive book summarizes the main advances in multifunctional nanoprobes for targeted imaging and therapy of gastric cancer, and explores the clinical translational prospects and challenges. Although more research is needed to overcome the substantial obstacles that impede the development and availability of nanotheranostic products, such nontrivial nanoagents are expected to revolutionize medical treatments and help to realize the potential of personalized medicine to diagnose, treat, and follow-up patients with cancer. Zhifei Dai is a Professor at the Department of Biomedical Engineering, College of Engineering, Peking University, China.

ISBN: 9789811000638

Standard No.: 10.1007/978-981-10-0063-8doiSubjects--Topical Terms:

342485
Nanomedicine.

LC Class. No.: R857.N34

Dewey Class. No.: 610.28

Advances in nanotheranostics II[electronic resource] :cancer theranostic nanomedicine /
LDR:02436nam a2200313 a 4500 001 456163
003 DE-He213
005 20160819115225.0
006 m d
007 cr nn 008maaau
008 161227s2016 si s 0 eng d
020 $a 9789811000638 $q (electronic bk.)
020 $a 9789811000614 $q (paper)
024 7 $a 10.1007/978-981-10-0063-8 $2 doi
035 $a 978-981-10-0063-8
040 $a GP $c GP
041 0 $a eng
050 4 $a R857.N34
072 7 $a MQW $2 bicssc
072 7 $a TEC009000 $2 bisacsh
082 0 4 $a 610.28 $2 23
090 $a R857.N34 $b A244 2016
245 0 0 $a Advances in nanotheranostics II $h [electronic resource] : $b cancer theranostic nanomedicine / $c edited by Zhifei Dai.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2016.
300 $a xi, 381 p. : $b ill., digital ; $c 24 cm.
490 1 $a Springer series in biomaterials science and engineering, $x 2195-0644 ; $v 7
520 $a This book surveys recent advances in theranostics based on magnetic nanoparticles, ultrasound contrast agents, silica nanoparticles and polymeric micelles. It presents magnetic nanoparticles, which offer a robust tool for contrast enhanced MRI imaging, magnetic targeting, controlled drug delivery, molecular imaging guided gene therapy, magnetic hyperthermia, and controlling cell fate. Multifunctional ultrasound contrast agents have great potential in ultrasound molecular imaging, multimodal imaging, drug/gene delivery, and integrated diagnostics and therapeutics. Due to their diversity and multifunctionality, polymeric micelles and silica-based nanocomposites are highly capable of enhancing the efficacy of multimodal imaging and synergistic cancer therapy. This comprehensive book summarizes the main advances in multifunctional nanoprobes for targeted imaging and therapy of gastric cancer, and explores the clinical translational prospects and challenges. Although more research is needed to overcome the substantial obstacles that impede the development and availability of nanotheranostic products, such nontrivial nanoagents are expected to revolutionize medical treatments and help to realize the potential of personalized medicine to diagnose, treat, and follow-up patients with cancer. Zhifei Dai is a Professor at the Department of Biomedical Engineering, College of Engineering, Peking University, China.
650 0 $a Nanomedicine. $3 342485
650 0 $a Nanostructured materials. $3 339604
650 1 4 $a Engineering. $3 372756
650 2 4 $a Biomedical Engineering. $3 382389
650 2 4 $a Nanotechnology. $3 192698
650 2 4 $a Imaging / Radiology. $3 463785
650 2 4 $a Biomaterials. $3 464277
650 2 4 $a Oncology. $3 205017
700 1 $a Dai, Zhifei. $3 654389
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
830 0 $a Springer series in biomaterials science and engineering ; $v v.3. $3 626988
856 4 0 $u http://dx.doi.org/10.1007/978-981-10-0063-8
950 $a Engineering (Springer-11647)